MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 06.12.2025
Land |
 Niederlande |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NYSE |
Anteile |
223 M |
Marktkapitalisierung |
$ 10 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 16.71 | -0.83 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.22 | 2.97 % | $ 175 M | Nasdaq Global Market |  China |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market |  USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.57 | -3.4 % | $ 2 M | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Castle Biosciences
CSTL
|
$ 38.53 | -0.26 % | $ 1.07 B | Nasdaq Global Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 11.99 | 0.84 % | $ 340 M | Nasdaq Capital Market | Israel |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DexCom
DXCM
|
$ 66.15 | -1.22 % | $ 25.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 226.11 | -0.17 % | $ 165 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.52 | 0.01 % | $ 18.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 26.92 | -0.81 % | $ 814 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.95 | -2.97 % | $ 1.07 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 101.73 | -3.34 % | $ 4.01 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.29 | -8.24 % | $ 105 K | Nasdaq Capital Market | USA |
 |
Co-Diagnostics
CODX
|
$ 0.31 | -9.7 % | $ 9.1 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 221.67 | -0.25 % | $ 40.2 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 103.94 | 1.83 % | $ 12.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 133.75 | -0.83 % | $ 21.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 196.94 | 2.05 % | $ 10.1 B | NYSE,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
$ 183.42 | 0.5 % | $ 20.4 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 7.63 | -2.8 % | $ 989 M | Nasdaq Global Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 405.95 | 0.86 % | $ 29.8 B | NYSE,SPB | Schweiz |
 |
Myriad Genetics
MYGN
|
$ 6.96 | -3.47 % | $ 631 M | Nasdaq Global Select Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 261.21 | -1.12 % | $ 21.9 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 181.89 | -2.51 % | $ 15 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
NeoGenomics
NEO
|
$ 11.99 | 1.14 % | $ 1.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 6.78 | -1.16 % | $ 1.47 B | Nasdaq Global Select Market,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 698.37 | -0.83 % | $ 57.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 67.15 | 0.79 % | $ 4.65 B | Nasdaq Global Select Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 139.73 | 0.05 % | $ 42.5 B | NYSE,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.43 | -4.8 % | $ 5.58 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 7.53 | -0.26 % | $ 472 M | Nasdaq Global Select Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Pacific Biosciences of California
PACB
|
$ 2.1 | -1.18 % | $ 533 M | Nasdaq Global Select Market,SPB | USA |